Myokardia


4 Biotechs with Near Term Catalysts: G1 Therapeutics, Inc. (GTHX), Sierra Oncology Inc (SRRA), Myokardia Inc (MYOK), Jounce Therapeutics (JNCE)

Written by Danny Cohen and Scott Matusow The biotech “run-up” trade has always attracted a wide-array of traders looking to take advantage of …

Myokardia Inc (MYOK) Q3:17 Update At First Glance

Shares of Myokardia Inc (NASDAQ:MYOK) are down nearly 3% Tuesday as investors digest the biotech firm’s third-quarter financial results. The company reported Q3 EPS …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts